TrialVaccine2014

Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults.

James F Cummings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.